{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T16:40:58Z","timestamp":1793724058894,"version":"4.6.1"},"reference-count":59,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,28]],"date-time":"2022-12-28T00:00:00Z","timestamp":1672185600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["UG3 TR002851"],"award-info":[{"award-number":["UG3 TR002851"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health and Care Research","doi-asserted-by":"publisher","award":["1UG3TR002851\u20130"],"award-info":[{"award-number":["1UG3TR002851\u20130"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/j.biopha.2022.114189","type":"journal-article","created":{"date-parts":[[2022,12,29]],"date-time":"2022-12-29T23:36:26Z","timestamp":1672356986000},"page":"114189","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["In vivo editing of the pan-endothelium by immunity evading simian adenoviral vector"],"prefix":"10.1016","volume":"158","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9077-3300","authenticated-orcid":false,"given":"Reka","family":"Lorincz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aluet Borrego","family":"Alvarez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher J.","family":"Walkey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samir A.","family":"Mendon\u00e7a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi Hong","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexa E.","family":"Martinez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0544-878X","authenticated-orcid":false,"given":"Cecilia","family":"Ljungberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason D.","family":"Heaney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William R.","family":"Lagor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David T.","family":"Curiel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2022.114189_bib1","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/s41586-021-03191-1","article-title":"The NIH Somatic Cell Genome Editing program","volume":"592","author":"Saha","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2022.114189_bib2","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1002\/jimd.12414","article-title":"Mucopolysaccharidoses type I gene therapy","volume":"44","author":"Hurt","year":"2021","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.biopha.2022.114189_bib3","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/s41434-018-0003-1","article-title":"Targeted in vivo knock-in of human alpha-1-antitrypsin cDNA using adenoviral delivery of CRISPR\/Cas9","volume":"25","author":"Stephens","year":"2018","journal-title":"Gene Ther."},{"key":"10.1016\/j.biopha.2022.114189_bib4","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.jconrel.2019.02.009","article-title":"Long-term correction of hemophilia B using adenoviral delivery of CRISPR\/Cas9","volume":"298","author":"Stephens","year":"2019","journal-title":"J. Control. Release: Off. J. Control. Release Soc."},{"key":"10.1016\/j.biopha.2022.114189_bib5","first-page":"560","volume":"63","author":"Lorincz","year":"2020","journal-title":"Adv. Alpha-1 Antitrypsin Gene Ther."},{"key":"10.1016\/j.biopha.2022.114189_bib6","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1182\/blood-2013-08-518266","article-title":"Targeting endothelial cells by gene therapy","volume":"122","author":"VandenDriessche","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.biopha.2022.114189_bib7","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.ymeth.2020.12.001","article-title":"AAV-mediated in vivo genome editing in vascular endothelial cells","volume":"194","author":"Wu","year":"2021","journal-title":"Methods"},{"key":"10.1016\/j.biopha.2022.114189_bib8","first-page":"38","article-title":"Robust genome editing in adult vascular endothelium by nanoparticle delivery of CRISPR-Cas9 plasmid DNA","author":"Zhang","year":"2022","journal-title":"Cell Rep."},{"key":"10.1016\/j.biopha.2022.114189_bib9","doi-asserted-by":"crossref","unstructured":"Lu, Z.H.; Dmitriev, I.P.; Brough, D.E.; Kashentseva, E.A.; Li, J.; Curiel, D.T. A new gorilla adenoviral vector with natural lung tropism avoids liver toxicity and is amenable for capsid engineering and vector retargeting, 2020, JVI.00265\u201300220, doi:10.1128\/JVI.00265\u201320%J Journal of Virology.","DOI":"10.1128\/JVI.00265-20"},{"key":"10.1016\/j.biopha.2022.114189_bib10","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1038\/labinvest.2014.78","article-title":"The myeloid-binding peptide adenoviral vector enables multi-organ vascular endothelial gene targeting","volume":"94","author":"Lu","year":"2014","journal-title":"Lab. Investig. ; a J. Tech. Methods Pathol."},{"key":"10.1016\/j.biopha.2022.114189_bib11","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1038\/nbt856","article-title":"Random peptide libraries displayed on adeno-associated virus to select for targeted gene therapy vectors","volume":"21","author":"M\u00fcller","year":"2003","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.biopha.2022.114189_bib12","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0037812","article-title":"Derivation of a myeloid cell-binding adenovirus for gene therapy of inflammation","volume":"7","author":"Alberti","year":"2012","journal-title":"PloS One"},{"key":"10.1016\/j.biopha.2022.114189_bib13","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.addr.2015.09.012","article-title":"PEGylation as a strategy for improving nanoparticle-based drug and gene delivery","volume":"99","author":"Suk","year":"2016","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.biopha.2022.114189_bib14","doi-asserted-by":"crossref","first-page":"652","DOI":"10.7150\/ijbs.64188","article-title":"Genome editing with AAV-BR1-CRISPR in postnatal mouse brain endothelial cells","volume":"18","author":"Song","year":"2022","journal-title":"Int J. Biol. Sci."},{"key":"10.1016\/j.biopha.2022.114189_bib15","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/s41467-017-00140-3","article-title":"Genome editing abrogates angiogenesis in vivo","volume":"8","author":"Huang","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biopha.2022.114189_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellimm.2017.11.006","article-title":"Preclinical models to assess the immunogenicity of AAV vectors","volume":"342","author":"Ertl","year":"2019","journal-title":"Cell Immunol."},{"key":"10.1016\/j.biopha.2022.114189_bib17","first-page":"167","article-title":"[Integration of AAV vectors and insertional mutagenesis]","volume":"32","author":"Rossi","year":"2016","journal-title":"Med. Sci.: M\/S"},{"key":"10.1016\/j.biopha.2022.114189_bib18","doi-asserted-by":"crossref","first-page":"4439","DOI":"10.1038\/s41467-019-12449-2","article-title":"High levels of AAV vector integration into CRISPR-induced DNA breaks","volume":"10","author":"Hanlon","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biopha.2022.114189_bib19","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/B978-0-12-800276-6.00009-7","article-title":"Targeted Adenoviral Vectors I: Transductional Targeting","author":"Dmitriev","year":"2016","journal-title":"Aden Vectors Gene Ther."},{"key":"10.1016\/j.biopha.2022.114189_bib20","doi-asserted-by":"crossref","first-page":"307","DOI":"10.2174\/156652311796150372","article-title":"Adenoviral vector immunity: its implications and circumvention strategies","volume":"11","author":"Ahi","year":"2011","journal-title":"Curr. gene Ther."},{"key":"10.1016\/j.biopha.2022.114189_bib21","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1002\/jcb.22328","article-title":"The influence of innate and pre-existing immunity on adenovirus therapy","volume":"108","author":"Zaiss","year":"2009","journal-title":"J. Cell Biochem"},{"key":"10.1016\/j.biopha.2022.114189_bib22","doi-asserted-by":"crossref","first-page":"2875","DOI":"10.4161\/hv.29594","article-title":"Pre-existing immunity against Ad vectors: humoral, cellular, and innate response, what's important?","volume":"10","author":"Fausther-Bovendo","year":"2014","journal-title":"Hum. Vaccin Immunother."},{"key":"10.1016\/j.biopha.2022.114189_bib23","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.3201\/eid1210.060078","article-title":"Chimpanzee adenovirus antibodies in humans, sub-Saharan Africa","volume":"12","author":"Xiang","year":"2006","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.biopha.2022.114189_bib24","article-title":"A single intranasal dose of chimpanzee adenovirus-vectored vaccine protects against SARS-CoV-2 infection in rhesus macaques","volume":"2","author":"Hassan","year":"2021","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.biopha.2022.114189_bib25","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.cell.2020.08.026","article-title":"A Single-Dose Intranasal ChAd Vaccine Protects Upper and Lower Respiratory Tracts against SARS-CoV-2","volume":"183","author":"Hassan","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.biopha.2022.114189_bib26","doi-asserted-by":"crossref","first-page":"3239","DOI":"10.1016\/j.vaccine.2017.04.062","article-title":"A prime-boost immunization regimen based on a simian adenovirus 36 vectored multi-stage malaria vaccine induces protective immunity in mice","volume":"35","author":"Fonseca","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.biopha.2022.114189_bib27","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.virol.2005.10.042","article-title":"Chimpanzee adenovirus vaccine protects against Zaire Ebola virus","volume":"346","author":"Kobinger","year":"2006","journal-title":"Virology"},{"key":"10.1016\/j.biopha.2022.114189_bib28","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1038\/gt.2012.91","article-title":"A myeloid cell-binding adenovirus efficiently targets gene transfer to the lung and escapes liver tropism","volume":"20","author":"Alberti","year":"2013","journal-title":"Gene Ther."},{"key":"10.1016\/j.biopha.2022.114189_bib29","first-page":"496","article-title":"Transient immunosuppression permits successful repetitive intravenous administration of an adenovirus vector","volume":"3","author":"Smith","year":"1996","journal-title":"Gene Ther."},{"key":"10.1016\/j.biopha.2022.114189_bib30","doi-asserted-by":"crossref","DOI":"10.1038\/mtm.2014.57","article-title":"Efficient genome editing in hematopoietic stem cells with helper-dependent Ad5\/35 vectors expressing site-specific endonucleases under microRNA regulation","volume":"2","author":"Saydaminova","year":"2015","journal-title":"Mol. Ther. - Methods Clin. Dev."},{"key":"10.1016\/j.biopha.2022.114189_bib31","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1038\/nbt1410","article-title":"Establishment of HIV-1 resistance in CD4+ T cells by genome editing using zinc-finger nucleases","volume":"26","author":"Perez","year":"2008","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.biopha.2022.114189_bib32","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1126\/science.7792603","article-title":"Transcriptional activation by tetracyclines in mammalian cells","volume":"268","author":"Gossen","year":"1995","journal-title":"Sci. (N. Y., N. Y. )"},{"key":"10.1016\/j.biopha.2022.114189_bib33","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1089\/crispr.2020.0021","article-title":"Promoter orientation within an AAV-CRISPR vector affects Cas9 expression and gene editing efficiency","volume":"3","author":"Fry","year":"2020","journal-title":"Crispr J."},{"key":"10.1016\/j.biopha.2022.114189_bib34","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/nn.2467","article-title":"A robust and high-throughput Cre reporting and characterization system for the whole mouse brain","volume":"13","author":"Madisen","year":"2010","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.biopha.2022.114189_bib35","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1038\/s41598-018-37130-4","article-title":"A simple protocol for isolating mouse lung endothelial cells","volume":"9","author":"Wang","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2022.114189_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.xpro.2021.100523","article-title":"Protocols for endothelial cell isolation from mouse tissues: kidney, spleen, and testis","volume":"2","author":"Dumas","year":"2021","journal-title":"STAR Protoc."},{"key":"10.1016\/j.biopha.2022.114189_bib37","doi-asserted-by":"crossref","first-page":"Iii27","DOI":"10.1161\/01.CIR.0000131515.03336.f8","article-title":"Role of endothelial dysfunction in atherosclerosis","volume":"109","author":"Davignon","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.biopha.2022.114189_bib38","first-page":"291","article-title":"Endothelial dysfunction and cardiovascular disease","volume":"2014","author":"Widmer","year":"2014","journal-title":"Glob. Cardiol. Sci. Pr."},{"key":"10.1016\/j.biopha.2022.114189_bib39","first-page":"197","article-title":"Evidence of endothelial dysfunction in the development of Alzheimer's disease: Is Alzheimer's a vascular disorder?","volume":"3","author":"Kelleher","year":"2013","journal-title":"Am. J. Cardiovasc Dis."},{"key":"10.1016\/j.biopha.2022.114189_bib40","doi-asserted-by":"crossref","first-page":"19750","DOI":"10.1002\/jcp.28575","article-title":"The interplay between glioblastoma and microglia cells leads to endothelial cell monolayer dysfunction via the interleukin-6-induced JAK2\/STAT3 pathway","volume":"234","author":"Couto","year":"2019","journal-title":"J. Cell Physiol."},{"key":"10.1016\/j.biopha.2022.114189_bib41","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1097\/SHK.0000000000000473","article-title":"THE ENDOTHELIUM IN SEPSIS","volume":"45","author":"Ince","year":"2016","journal-title":"Shock"},{"key":"10.1016\/j.biopha.2022.114189_bib42","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21228793","article-title":"Endothelial damage in acute respiratory distress syndrome","volume":"21","author":"Vassiliou","year":"2020","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.biopha.2022.114189_bib43","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.amjms.2021.12.010","article-title":"Endothelial Dysfunction in Covid-19 Infection","volume":"363","author":"Otifi","year":"2022","journal-title":"Am. J. Med Sci."},{"key":"10.1016\/j.biopha.2022.114189_bib44","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1038\/nature13864","article-title":"Promoterless gene targeting without nucleases ameliorates haemophilia B in mice","volume":"517","author":"Barzel","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2022.114189_bib45","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1016\/j.celrep.2018.02.014","article-title":"A single administration of CRISPR\/Cas9 lipid nanoparticles achieves robust and persistent in vivo genome editing","volume":"22","author":"Finn","year":"2018","journal-title":"Cell Rep."},{"key":"10.1016\/j.biopha.2022.114189_bib46","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1038\/nbt.4005","article-title":"Structure-guided chemical modification of guide RNA enables potent non-viral in vivo genome editing","volume":"35","author":"Yin","year":"2017","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.biopha.2022.114189_bib47","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1002\/jgm.2874","article-title":"Pulmonary vasculature directed adenovirus increases epithelial lining fluid alpha-1 antitrypsin levels","volume":"18","author":"Buggio","year":"2016","journal-title":"J. Gene Med."},{"key":"10.1016\/j.biopha.2022.114189_bib48","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1038\/sj.gt.3302347","article-title":"Evaluation of toxicity from high-dose systemic administration of recombinant adenovirus vector in vector-na\u00efve and pre-immunized mice","volume":"12","author":"Varnavski","year":"2005","journal-title":"Gene Ther."},{"key":"10.1016\/j.biopha.2022.114189_bib49","doi-asserted-by":"crossref","first-page":"10443","DOI":"10.1021\/acsnano.2c00909","article-title":"Efficient genome editing achieved via plug-and-play adenovirus piggyback transport of Cas9\/gRNA complex on viral capsid surface","volume":"16","author":"Lu","year":"2022","journal-title":"ACS Nano"},{"key":"10.1016\/j.biopha.2022.114189_bib50","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1099\/vir.0.81989-0","article-title":"Generation of an adenoviral vaccine vector based on simian adenovirus 21","volume":"87","author":"Roy","year":"2006","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.biopha.2022.114189_bib51","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1128\/JVI.76.3.1100-1108.2002","article-title":"Artificial extension of the adenovirus fiber shaft inhibits infectivity in coxsackievirus and adenovirus receptor-positive cell lines","volume":"76","author":"Seki","year":"2002","journal-title":"J. Virol."},{"key":"10.1016\/j.biopha.2022.114189_bib52","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/jgm.1530","article-title":"Creation of a panel of vectors based on ape adenovirus isolates","volume":"13","author":"Roy","year":"2011","journal-title":"J. Gene Med."},{"key":"10.1016\/j.biopha.2022.114189_bib53","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.devcel.2014.07.018","article-title":"A gene regulatory network controls the binary fate decision of rod and bipolar cells in the vertebrate retina","volume":"30","author":"Wang","year":"2014","journal-title":"Dev. Cell"},{"key":"10.1016\/j.biopha.2022.114189_bib54","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1126\/science.aad5177","article-title":"In vivo gene editing in dystrophic mouse muscle and muscle stem cells","volume":"351","author":"Tabebordbar","year":"2016","journal-title":"Sci. (N. Y., N. Y. )"},{"key":"10.1016\/j.biopha.2022.114189_bib55","doi-asserted-by":"crossref","first-page":"4805","DOI":"10.1128\/jvi.70.7.4805-4810.1996","article-title":"Efficient generation of recombinant adenovirus vectors by homologous recombination in Escherichia coli","volume":"70","author":"Chartier","year":"1996","journal-title":"J. Virol."},{"key":"10.1016\/j.biopha.2022.114189_bib56","doi-asserted-by":"crossref","first-page":"6839","DOI":"10.1128\/jvi.70.10.6839-6846.1996","article-title":"Generation of recombinant adenovirus vectors with modified fibers for altering viral tropism","volume":"70","author":"Krasnykh","year":"1996","journal-title":"J. Virol."},{"key":"10.1016\/j.biopha.2022.114189_bib57","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1016\/j.ymthe.2017.03.029","article-title":"5 year expression and neutrophil defect repair after gene therapy in Alpha-1 antitrypsin deficiency","volume":"25","author":"Mueller","year":"2017","journal-title":"Mol. Ther."},{"key":"10.1016\/j.biopha.2022.114189_bib58","doi-asserted-by":"crossref","first-page":"7498","DOI":"10.1128\/jvi.70.11.7498-7509.1996","article-title":"Evaluation of the concentration and bioactivity of adenovirus vectors for gene therapy","volume":"70","author":"Mittereder","year":"1996","journal-title":"J. Virol."},{"key":"10.1016\/j.biopha.2022.114189_bib59","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s00418-014-1301-3","article-title":"Use of labeled tomato lectin for imaging vasculature structures","volume":"143","author":"Robertson","year":"2015","journal-title":"Histochem Cell Biol."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332222015785?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332222015785?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T11:23:09Z","timestamp":1779794589000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332222015785"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":59,"alternative-id":["S0753332222015785"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2022.114189","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In vivo editing of the pan-endothelium by immunity evading simian adenoviral vector","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2022.114189","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"114189"}}